The largest database of trusted experimental protocols

5 protocols using growth factor reduced (gfr)

1

Culturing HBL-100 Cells for Conditioned Medium

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HBL-100 cell line was cultured in DMEM/F12 supplemented with 10% FBS. Conditioned medium (CM) was collected when the cultured HBL-100 cells reached 70% confluence HBL-100 after 24 hours. After centrifugation and filtration through a 0.22 μm filter to remove the cells, the medium was stored at -80°C. The CM was thawed at 4°C overnight and was supplemented with 2% matrigel (Growth Factor Reduced; BD Biosciences, CA, USA) before used. DMEM/F12 containing 10% FBS was used as a control.
+ Open protocol
+ Expand
2

Hepatic Differentiation of Human iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSC lines (UC01 and UC15) and ESC line (H1) cultured in chemically defined mTeSR1 medium (Stem Cell Technologies) on a Matrigel matrix (Growth Factor Reduced, BD Bioscience). The human iPSC colonies were passaged using Accutase (life).
For the HB differentiation, we started the definitive endoderm (DE) stage induction first. Briefly, when human iPSCs reached nearly 70% confluence, mTeSR1 medium was replaced with differentiation medium (RPMI1640 [Gibco], supply with 1 × B27[minus insulin, Invitrogen]), containing 100 ng/mL Activin A (R&D Systems) and 3 μM CHIR99021 (CHIR) for 1 day, and on the following 2 days, CHIR was omitted from the medium. Then, DE population was cultured in differentiation medium, containing 20 ng/mL BMP2, 20 ng/mL BMP4, and 30 ng/mL FGF4 for 4 days to specify hepatic endoderm (HE), and then subsequently differentiated into HBs by treatment with differentiation medium containing 20 ng/mL BMP4 and 20 ng/mL HGF for 3 days. The medium was changed daily during the differentiation period. All grow factors were purchased from PeproTech except that indicate.
+ Open protocol
+ Expand
3

Measuring Angiogenesis in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal work was approved by the OHSU Institutional Animal Use and Care Committee. WT male and female C57Bl/6 N and Ddx58 (−/−) 8–10-week-old mice were purchased from Jackson Labs and injected subcutaneously with Growth factor reduced (Matrigel BD) with 400 ng mL−1 recombinant human bFGF (Millipore). One-week later Matrigel plugs, as well as lung, liver, and heart, were harvested from mice and RNA was isolated using the Eurx RNA purification kit according to manufacturer’s instructions. Matrigel plugs were homogenized and analyzed for hemoglobin content using a colorimetric assay kit (Sigma). In addition, RNA from tissue was used to analyze endothelial activity using the Qiagen endothelial cell activity qRT-PCR array according to manufacturer’s instructions.
+ Open protocol
+ Expand
4

Ewing Sarcoma Cell Line Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were obtained from ATCC or different partner institutes of EuroBoNeT (Table S1) [37] (link). All EWSR1 translocation confirmed Ewing sarcoma (ES) cell lines used in this study were grown in RPMI 1640 (PAA Laboratories GmbH, Austria) supplemented with 1% Penicillin-Streptomycin (PAA Laboratories GmbH, Austria) and 10% Foetal Calf Serum (Biosera, UK). Three cell lines (STA-ET 2.1, STA-ET10, WE-68) needed to be cultivated in gelatine-coated culture flasks to allow cells to attach. For growth factor experiments cell lines were grown on coverslips (d = 13 mm) in 24-well plates (Costar, USA) with 4×104 cells per well. Poorly attaching cell lines (e.g. STA-ET 2.1, STA-ET10, WE-68) were seeded on either Matrigel or gelatine coated coverslips (growth factor reduced, BD Biosciences, UK). After adaption for 2 days, cells were serum-starved in RPMI 1640 supplemented with 1% Penicillin-Streptomycin for 24 hr and treated with IGF2 (50 ng ml−1, R&D systems) for 1 hr at 37°C. Finally cells were fixed in 4% (v/v) formaldehyde for 15 min at room temperature (RT).
+ Open protocol
+ Expand
5

Cell Migratory and Invasive Potential

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transwell migration and matrigel invasion assays were carried out utilizing Transwell chambers as indicated by the producer's guidelines. A matrigel grid was covered in the transwell membrane and utilized for the cell invasion test. In short, 1×10 5 cells/well in DMEM (100L,0.6%FBS) were put in the upper Transwell chamber (Corning Incorporated, NY, USA) that had been pre-coated with matrigel (Growth factor reduced, BD Biosciences, MD, USA). DMEM was loaded into the base chambers (20 % FBS). In the upper Transwell chamber, 1×10 5 cells/well in DMEM (100L, 0.5 % FBS) were placed for the migration test (Corning Incorporated, NY, USA).The base chambers were loaded up with DMEM (20% FBS). After 24 h, the cells were xed and stained in both the Transwell migration and matrigel invasion examine. Haphazardly chose elds were checked under a reversed magnifying lens (200 × magni cation, Carl ZEISS, Jena, German) and a normal worth was utilized as the quantity of attacked cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!